Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Ospemifene for VVA in Women with Intact Uterus
NCT01585558Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ospemifene in vulvovaginal atrophy (VVA), sponsored by Shionogi & Co., Ltd.. Started May 2006; status: completed.
02
Drugs
ospemifene
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT01585558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585558.